“Can DPP-4 Enhibitors and SGLT-2 Inhibitors Pleotropic Effects Be Extended to Treat Diabetic Nephropathy?”. 2023. Journal of Medicine 24 (1): 43-49. https://doi.org/10.3329/jom.v24i1.64903.